Literature DB >> 21704405

Residual DNA and chromosomal damage in ex vivo irradiated blood lymphocytes correlated with late normal tissue response to breast radiotherapy.

Melvin Lee Kiang Chua1, Navita Somaiah, Roger A'Hern, Sue Davies, Lone Gothard, John Yarnold, Kai Rothkamm.   

Abstract

PURPOSE: To test the association of DNA double-strand break (DSB) repair and chromosomal radiosensitivity in ex vivo irradiated blood lymphocytes with late-onset normal tissue responses following breast radiotherapy.
METHODS: Breast cancer patients with minimal (controls) or marked late radiotherapy changes (cases) were retrospectively selected. DSB were quantified by γH2AX/53BP1 immunofluorescence microscopy 0.5 and 24 h after exposure of unstimulated blood lymphocytes to 0.5 and 4 Gy X-rays, respectively. Chromosomal aberrations were scored in blood lymphocyte metaphases after 6 Gy X-rays.
RESULTS: Despite similar foci levels at 0.5 h in cases (n=7) and controls (n=7), foci levels 24 h after 4 Gy irradiation differed significantly between them (foci per cell were 12.8 in cases versus 10.2 in controls, p=0.004). Increased chromosomal radiosensitivity was also observed in cases (aberrations per cell were 5.84 in cases versus 3.79 in controls, p=0.001) with exchange and deletion type aberrations contributing equally to the difference between cases and controls. Residual foci correlated with formation of deletions (Spearman's R=0.589, p=0.027) but not exchanges (R=0.367, p=0.197) in blood lymphocytes from the same patients.
CONCLUSIONS: Higher levels of exchange type aberrations observed among radiosensitive breast cancer patients suggest a role for DSB misrepair, in addition to residual damage, as determinants of late normal tissue damage. Correlation of residual foci levels with deletion type aberration yields in the same cohort confirms their mechanistic linkage.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21704405     DOI: 10.1016/j.radonc.2011.05.071

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  17 in total

1.  Dicentric Dose Estimates for Patients Undergoing Radiotherapy in the RTGene Study to Assess Blood Dosimetric Models and the New Bayesian Method for Gradient Exposure.

Authors:  Jayne Moquet; Manuel Higueras; Ellen Donovan; Sue Boyle; Stephen Barnard; Clare Bricknell; Mingzhu Sun; Lone Gothard; Grainne O'Brien; Lourdes Cruz-Garcia; Christophe Badie; Elizabeth Ainsbury; Navita Somaiah
Journal:  Radiat Res       Date:  2018-09-20       Impact factor: 2.841

Review 2.  Deoxyribonucleic acid damage-associated biomarkers of ionising radiation: current status and future relevance for radiology and radiotherapy.

Authors:  G Manning; K Rothkamm
Journal:  Br J Radiol       Date:  2013-05-09       Impact factor: 3.039

3.  Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity.

Authors:  Pavel Lobachevsky; Trevor Leong; Patricia Daly; Jai Smith; Nickala Best; Jonathan Tomaszewski; Ella R Thompson; Na Li; Ian G Campbell; Roger F Martin; Olga A Martin
Journal:  Cancer Lett       Date:  2016-09-28       Impact factor: 8.679

4.  Comparison of established and emerging biodosimetry assays.

Authors:  K Rothkamm; C Beinke; H Romm; C Badie; Y Balagurunathan; S Barnard; N Bernard; H Boulay-Greene; M Brengues; A De Amicis; S De Sanctis; R Greither; F Herodin; A Jones; S Kabacik; T Knie; U Kulka; F Lista; P Martigne; A Missel; J Moquet; U Oestreicher; A Peinnequin; T Poyot; U Roessler; H Scherthan; B Terbrueggen; H Thierens; M Valente; A Vral; F Zenhausern; V Meineke; H Braselmann; M Abend
Journal:  Radiat Res       Date:  2013-07-17       Impact factor: 2.841

Review 5.  Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?

Authors:  Carsten Herskind; Christopher J Talbot; Sarah L Kerns; Marlon R Veldwijk; Barry S Rosenstein; Catharine M L West
Journal:  Cancer Lett       Date:  2016-03-02       Impact factor: 8.679

6.  DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy.

Authors:  Melvin Lee Kiang Chua; Simon Horn; Navita Somaiah; Sue Davies; Lone Gothard; Roger A'Hern; John Yarnold; Kai Rothkamm
Journal:  Radiat Environ Biophys       Date:  2014-03-13       Impact factor: 1.925

7.  Gamma-H2AX-based dose estimation for whole and partial body radiation exposure.

Authors:  Simon Horn; Stephen Barnard; Kai Rothkamm
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

8.  Gamma-H2AX biodosimetry for use in large scale radiation incidents: comparison of a rapid '96 well lyse/fix' protocol with a routine method.

Authors:  Jayne Moquet; Stephen Barnard; Kai Rothkamm
Journal:  PeerJ       Date:  2014-03-06       Impact factor: 2.984

9.  Differences in DNA Repair Capacity, Cell Death and Transcriptional Response after Irradiation between a Radiosensitive and a Radioresistant Cell Line.

Authors:  Mireia Borràs-Fresneda; Joan-Francesc Barquinero; Maria Gomolka; Sabine Hornhardt; Ute Rössler; Gemma Armengol; Leonardo Barrios
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

10.  Investigating γ H2AX as a Biomarker of Radiosensitivity Using Flow Cytometry Methods.

Authors:  Lindsay A Beaton; Leonora Marro; Shawn Malone; Sara Samiee; Scott Grimes; Kyle Malone; Ruth C Wilkins
Journal:  ISRN Radiol       Date:  2013-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.